In addition, a time-dependent cell death profile, containing a peak apoptotic response followed by a decline in signal due to a diminishing population of tumor cells available to undergo apoptosis, has been observed in some pre-clinical studies that administered either 1 or 2 doses of chemotherapy and then measured radiolabeled Annexin-V accumulation over time (16–19). Here, ANXA5 is linked to neoplasm.